Skip to main content
Clinical Trials/CTRI/2023/07/055176
CTRI/2023/07/055176
Recruiting
Phase 2

A prospective randomized controlled double blinded clinical trial evaluating the effect of four commonly prescribed analgesics on pulpal sensibility tests - Nil

Dr Rajat kapur0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K040- Pulpitis
Sponsor
Dr Rajat kapur
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Rajat kapur

Eligibility Criteria

Inclusion Criteria

  • Adult males \& females between 18\-65 years of age with moderate to severe pain due to symptomatic irreversible pulpitis (SIP) will be selected for this study. The subjects should not have used any analgesic or anti\-depressant in past 6 hrs.

Exclusion Criteria

  • 1\) If the subject has consumed an analgesic or an anti\-depressant less than six hours before presentation to the dental office will be excluded.
  • 2\) A selected candidate who refuses to sign the informed consent to be a part of this study shall not be included in the study.
  • 3\) Any subject who is allergic to any of the drugs being studied will be excluded from the study or if for medical reasons cannot be prescribed NSAIDs will also not be included.
  • 4\) If the tooth with SIP does not respond to cold test or If the tooth has periapical disease, it will be excluded from the study.
  • 5\) Participants with American Society of Anesthesiology (ASA) physical status \> 1 will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials